MARY HADAD: Open Payments
NPI 1619553815 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 55 payments from 15 companies in 2025. Trend: 2023 $1,473 · 2024 $1,592 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $185 |
| Vanda Pharmaceuticals Inc. | 7 | $138 |
| Alkermes, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 5 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| Corium, LLC | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Supernus Pharmaceuticals, Inc. | 3 | $46 |
Products named: VRAYLAR, FANAPT, ARISTADA, Auvelity, Jornay PM, CAPLYTA, INVEGA SUSTENNA, Azstarys.
Industry payments across FL — which companies pay providers there.
